Nurse counselling and personalized survivorship care plans for head and neck cancer survivors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial will assign about 180 patients treated for stage I–IVA head and neck mucosal cancer to either usual care or an intervention combining a survivorship care nurse motivational interviewing session with individualized treatment summary and survivorship care plans (TSSPs) delivered to patients and their providers. Data will be collected at baseline (3–6 months post-treatment) and at 3, 6, and 12 months post-baseline with quarterly patient surveys to track outcomes. The primary outcome is physician implementation of survivorship care recommendations over 12 months, and secondary outcomes include adherence to follow-up schedules, quality of life, patient satisfaction, and feedback on the TSSP and counselling. The intervention builds on a small pilot at the same center that demonstrated feasibility and a higher rate of physician implementation.

Why it matters

Who can join: the full rules

Patient Participants

Inclusion Criteria:

* Age 18 years or older
* Willing to provide informed consent
* Diagnosis of stage I-IVA head and neck mucosal cancer (larynx, hypopharynx, oral cavity, oropharynx, nasopharynx)
* Last definitive treatment (surgery, chemotherapy, radiotherapy) between 3 and 6 months prior to enrollment
* English speaking, reading and writing

Exclusion Criteria:

* Second concurrent non-cutaneous malignancy
* Metastatic disease
* Clinically apparent cognitive impairment
* Suspected residual disease after treatment completion

Where it's running

• Victoria Hospital, London Health Sciences Centre
  London, Ontario, Canada Recruiting

Study contacts

• Principal investigator: Danielle MacNeil, MD, FRCSC — Department of Otolaryngology-Head & Neck Surgery, Western University Canada
• Study coordinator: Agnieszka Dzioba, PhD
• Email: Agnieszka.Dzioba@lhsc.on.ca
• Phone: 519-685-8500

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Improving nasal-sounding speech and swallowing in head and neck cancer survivors with velopharyngeal dysfunction

  This pilot effort tests whether injecting material to 'plump' the back wall of the throat (pharyngeal wall augmentation) can help head and neck cancer survivors with velopharyngeal dysfunction speak less nasally and swallow better.

  Recruiting University of Virginia · Charlottesville, Virginia · NCT07264036

• A program to support head and neck cancer survivors and their caregivers

  This study is testing a new support program for head and neck cancer survivors and their caregivers to see if it helps them manage symptoms and reduces stress compared to regular care.

  Recruiting Medical University of South Carolina · Charleston, South Carolina · NCT05811936

• Improving body image for head and neck cancer survivors

  This study is testing a new video therapy program to see if it can help head and neck cancer survivors feel better about their body image and improve their overall well-being.

  Recruiting at 5 sites Medical University of South Carolina · Detroit, Michigan and 4 other locations · NCT05442957

• Phenotype-based Pain Guidance for Head and Neck Cancer-Related Pain (pilot)

  This pilot test sees if tailoring pain treatment to a patient’s pain type can reduce head and neck cancer pain in adults who haven’t started cancer treatment yet.

  Recruiting Phase 2 Shaukat Khanum Memorial Cancer Hospital & Research Centre · Lahore, Punjab Province · NCT07919444

• Airway ultrasound in head and neck cancer patients

  This observational study tests whether neck ultrasound measurements of the airway match CT measurements in adults with maxillofacial cancer undergoing surgery with anesthesia.

  Recruiting at 2 sites University Hospital Dubrava · Zagreb, City of Zagreb and 1 other locations · NCT07910149

• Safe use of metformin and naproxen to help prevent cancer in people with Fanconi anemia

  This study tests whether metformin and naproxen can lower the chance of cancer developing in adults with Fanconi anemia.

  Recruiting at 2 sites Phase 1 Rockefeller University · Minneapolis, Minnesota and 1 other locations · NCT07901959

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.